4.8 Article

CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Anti-CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non-alcoholic steatohepatitis models

Taesik Gwag et al.

Summary: The study suggests that anti-CD47 antibody may serve as a new therapeutic option for obesity-associated NASH and liver fibrosis. By inhibiting liver immune cell infiltration, inflammation, and fibrosis, anti-CD47 antibody can prevent the progression of NAFLD/NASH.

LIVER INTERNATIONAL (2022)

Article Chemistry, Multidisciplinary

Histone deacetylase inhibitor givinostat attenuates nonalcoholic steatohepatitis and liver fibrosis

He-ming Huang et al.

Summary: Givinostat demonstrated therapeutic potential in treating nonalcoholic steatohepatitis (NASH) by alleviating inflammation and attenuating hepatic fibrosis, as shown in both in vivo and in vitro studies.

ACTA PHARMACOLOGICA SINICA (2022)

Article Gastroenterology & Hepatology

Epigenetic Silencing of RIPK3 in Hepatocytes Prevents MLKL -mediated Necroptosis From Contributing to Liver Pathologies

Simon P. Preston et al.

Summary: This study provides compelling evidence that necroptosis is disabled in hepatocytes during homeostasis and in the pathologic conditions tested.

GASTROENTEROLOGY (2022)

Article Multidisciplinary Sciences

In vitro ballooned hepatocytes can be produced by primary human hepatocytes and hepatic stellate cell sheets

Nobuhiro Hasui et al.

Summary: In this study, a new in vitro model of ballooned hepatocytes in NASH was developed using engineered cell sheets. The model successfully replicated the histological features of ballooned hepatocytes in human NASH and revealed the underlying mechanism of fibrosis contributing to the development of ballooned hepatocytes.

SCIENTIFIC REPORTS (2022)

Article Medicine, General & Internal

Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

Arun J. Sanyal et al.

Summary: In this study involving patients with nonalcoholic fatty liver disease, advanced fibrosis stages F3 and F4 were associated with increased risks of liver-related complications and death over a median of 4 years of follow-up. Advanced fibrosis was also related to an increased incidence of liver decompensation events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, Research & Experimental

Differential role of MLKL in alcohol-associated and non-alcohol-associated fatty liver diseases in mice and humans

Tatsunori Miyata et al.

Summary: The study found that MLKL plays a different role in ALD and NAFL/NASH mouse models, and suggested that RIP1-RIP3-MLKL can be used as biomarkers to distinguish alcohol-associated hepatitis (AH) from NASH.

JCI INSIGHT (2021)

Review Biochemistry & Molecular Biology

Mechanisms and disease consequences of nonalcoholic fatty liver disease

Rohit Loomba et al.

Summary: NAFLD and NASH are leading chronic liver diseases worldwide, causing progressive liver injury that can lead to cirrhosis and hepatocellular carcinoma. These diseases are associated with hepatic glucose and lipid metabolism, and are influenced by genetic, epigenetic, and environmental factors.
Article Gastroenterology & Hepatology

Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort

Stephen A. Harrison et al.

Summary: In a cohort of asymptomatic middle-aged Americans, the prevalence of NAFLD was 38%, NASH was 14%, and significant liver fibrosis was present in 6% of the participants.

JOURNAL OF HEPATOLOGY (2021)

Article Cell Biology

Hepatocyte TLR4 triggers inter-hepatocyte Jagged1/Notch signaling to determine NASH-induced fibrosis

Junjie Yu et al.

Summary: Elevated hepatocyte Jagged1 expression plays a crucial role in Notch-induced liver fibrosis in NASH. Inhibition of Jagged1 may serve as a potential therapeutic target for patients with NASH.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Resolvin D1 promotes the targeting and clearance of necroptotic cells

Brennan D. Gerlach et al.

CELL DEATH AND DIFFERENTIATION (2020)

Article Gastroenterology & Hepatology

Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer

Guangyan Wei et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)

Article Gastroenterology & Hepatology

Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease

Amine Majdi et al.

JOURNAL OF HEPATOLOGY (2020)

Article Cell Biology

Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis

Bishuang Cai et al.

CELL METABOLISM (2020)

Review Pharmacology & Pharmacy

The molecular basis for current targets of NASH therapies

Kamran Qureshi et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)

Article Gastroenterology & Hepatology

Mechanisms of Fibrosis Development in NASH

Robert F. Schwabe et al.

GASTROENTEROLOGY (2020)

Review Gastroenterology & Hepatology

New drugs for non-alcoholic steatohepatitis

Ana-Carolina Cardoso et al.

LIVER INTERNATIONAL (2020)

Review Gastroenterology & Hepatology

Lytic cell death in metabolic liver disease

Jeremie Gautheron et al.

JOURNAL OF HEPATOLOGY (2020)

Article Medicine, General & Internal

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

Kausik K. Ray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, Research & Experimental

Targeting macrophage checkpoint inhibitor SIRPα for anticancer therapy

Jie Liu et al.

JCI INSIGHT (2020)

Article Biochemical Research Methods

Protocol Protocol for Primary Mouse Hepatocyte Isolation

Meital Charni-Natan et al.

STAR PROTOCOLS (2020)

Review Immunology

Efferocytosis in health and disease

Amanda C. Doran et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Gastroenterology & Hepatology

Non-alcoholic fatty liver disease - A global public health perspective

Zobair M. Younossi

JOURNAL OF HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis

Stephen A. Harrison et al.

JOURNAL OF HEPATOLOGY (2019)

Review Medicine, Research & Experimental

Necroptosis: a crucial pathogenic mediator of human disease

Mary E. Choi et al.

JCI INSIGHT (2019)

Article Gastroenterology & Hepatology

Macrophage Raptor Deficiency-Induced Lysosome Dysfunction Exacerbates Nonalcoholic Steatohepatitis

Wenli Liu et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Apoptosis and necroptosis in the liver: a matter of life and death

Robert F. Schwabe et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Cell Biology

Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis

Changyu Zhu et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Medicine, Research & Experimental

Hepatic neuregulin 4 signaling defines an endocrine checkpoint for steatosis-to-NASH progression

Liang Guo et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Biochemical Research Methods

Salmon provides fast and bias-aware quantification of transcript expression

Rob Patro et al.

NATURE METHODS (2017)

Article Medicine, Research & Experimental

Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy

Tadahiko Yanagita et al.

JCI INSIGHT (2017)

Article Gastroenterology & Hepatology

Receptor interacting protein 3 protects mice from high-fat diet-induced liverinjury

Sanjoy Roychowdhury et al.

HEPATOLOGY (2016)

Article Endocrinology & Metabolism

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

Elena Buzzetti et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2016)

Article Biochemistry & Molecular Biology

Sequential Engagement of Distinct MLKL Phosphatidylinositol-Binding Sites Executes Necroptosis

Giovanni Quarato et al.

MOLECULAR CELL (2016)

Article Multidisciplinary Sciences

CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis

Yoko Kojima et al.

NATURE (2016)

Article Medicine, Research & Experimental

Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis

Marta B. Afonso et al.

CLINICAL SCIENCE (2015)

Letter Gastroenterology & Hepatology

Necroptosis in Nonalcoholic Steatohepatitis

Jeremie Gautheron et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)

Article Medicine, Research & Experimental

A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis

Jeremie Gautheron et al.

EMBO MOLECULAR MEDICINE (2014)

Article Gastroenterology & Hepatology

Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance

Tom Luedde et al.

GASTROENTEROLOGY (2014)

Article Multidisciplinary Sciences

Selection and evaluation of clinically relevant AAV variants in a xenograft liver model

Leszek Lisowski et al.

NATURE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Medicine, General & Internal

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

Teresa Coelho et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Gastroenterology & Hepatology

Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis

Yury Popov et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)

Article Gastroenterology & Hepatology

Pan-Caspase Inhibitor VX-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis

Rafal P. Witek et al.

HEPATOLOGY (2009)

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Gastroenterology & Hepatology

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

DE Kleiner et al.

HEPATOLOGY (2005)